scout
|Videos|June 28, 2016

The Impact of CheckMate-205 for Patients With Classical Hodgkin Lymphoma

Anas Younes, MD, medical oncologist at Memorial Sloan Kettering Cancer Center in New York, discusses the potential impact of CheckMate-205 nivolumab as a treatment for patients with Hodgkin lymphoma.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME